High fidelity of whole-genome amplified DNA on high-density single nucleotide polymorphism arrays  by Xing, Jinchuan et al.
Genomics 92 (2008) 452–456
Contents lists available at ScienceDirect
Genomics
j ourna l homepage: www.e lsev ie r.com/ locate /ygenoHigh ﬁdelity of whole-genome ampliﬁed DNA on high-density single nucleotide
polymorphism arrays
Jinchuan Xing, W. Scott Watkins, Yuhua Zhang, David J. Witherspoon, Lynn B. Jorde ⁎
Department of Human Genetics, Eccles Institute of Human Genetics, University of Utah, Salt Lake City, UT, 84112, USA⁎ Corresponding author. Fax: +1 801 585 9148.
E-mail address: lbj@genetics.utah.edu (L.B. Jorde).
0888-7543/$ – see front matter © 2008 Elsevier Inc. Al
doi:10.1016/j.ygeno.2008.08.007a b s t r a c ta r t i c l e i n f oArticle history: Current microarray technolo
Received 24 June 2008
Accepted 11 August 2008
Available online 27 September 2008
Keywords:
Whole-genome ampliﬁcation
WGA
Single nucleotide polymorphism arraygy allows researchers to genotype a large number of SNPs with relatively small
amounts of DNA. Nevertheless, researchers and clinicians still frequently face the problem of acquiring
enough high-quality DNA for analysis. Whole-genome ampliﬁcation (WGA) methods offer a solution for this
problem, and earlier studies have shown that WGA samples perform reasonably well in small-scale genetic
analyses (e.g. Affymetrix 10K array). To determine the performance of WGA products on a large-scale
genotyping array, we compared the Affymetrix 250K array genotyping results of genomic DNA and their
WGA products from four individuals. Our results indicate that WGA product performs well on the 250K array
compared to genomic DNA, especially when using the BRLMM calling algorithm. WGA samples have high call
rates (97.5% on average, compared to 99.4% for genomic DNA) and excellent concordance rates with their
corresponding genomic DNA samples (98.7% on average). In addition, no apparent systematic genomic
ampliﬁcation bias can be detected. This study demonstrates that, although there is a slight decrease in the
total call rates, WGA methods provide a reliable approach for increasing the amount of DNA samples for use
with a common SNP genotyping array.
© 2008 Elsevier Inc. All rights reserved.IntroductionSingle nucleotide polymorphisms (SNPs) are the most common
genetic variants in the human genome, and it is believed that more
than 10million commonSNPswithminor-allele frequencyN1% exist in
the genome [1,2]. As such, SNPs playan important role in genome-wide
association and population genetic studies [3]. With the recent
development of microarray-based whole-genome SNP genotyping
technology, it is now possible to genotype onemillion SNPs on a single
microarray (e.g., Affymetrix Human SNP Array 6.0 and Illumina
Human1M BeadChip). These high-density arrays have dramatically
reduced the amount of DNA required for large-scale genotyping.
Nevertheless, insufﬁcient quantities of DNA remain a challenge for
some studies, especially when the source of DNA is limited or has low
quality (e.g., tumor tissue samples, mouthwash, archival samples, etc).
To increase the amount of usable DNA in low-quantity samples, a
number of in vitro whole-genome ampliﬁcation (WGA) approaches
have been proposed in recent years (see [4] for review). The multiple
displacement ampliﬁcation with Φ29 polymerase method, described
in 2002 [5], has been shown to have a number of advantages over
other methods. It has a high degree of ﬁdelity, large ampliﬁcation
products, and even ampliﬁcation across the genome [4]. Several
earlier studies have shown that WGA products perform reasonably
well in small-scale genetic analyses including Affymetrix 10K SNPl rights reserved.array [6,7]. Here, we investigate the performance of theWGA products
on an Affymetrix 250K mapping array.
Materials and methods
Genomic DNA extraction and whole-genome ampliﬁcation
Genomic DNA used for this study was extracted from blood
samples of six unrelated donors using standard phenol/chloroform
extraction procedures or a Puregene DNA extraction kit (Qiagen,
Valencia, CA, USA) more than 10 years ago and have been stored in TE
buffer at 4 °C. Whole-genome ampliﬁcation was performed on four of
these samples using a REPLI-gmini kit (Qiagen) following the protocol
in the manufacturer's manual. 10 ng of puriﬁed genomic DNA was
used as template, and the ampliﬁcation product was normalized to a
concentration of 50 ng/µl prior to the microarray experiment.
Genotyping
High-throughputmicroarray genotyping of approximately 262,000
SNPs was performed using one array (version NspI) from the
Affymetrix GeneChip® Human Mapping 500K Array set (Affymetrix,
Santa Clara, CA, USA). The recommended protocol as described in the
Affymetrix manual was followed. Brieﬂy, 250 ng of genomic DNA or
WGA product was digested with NspI (New England Biolabs, Beverly,
MA, USA) and ligated to an Nsp1 adapter (Affymetrix) using T4 DNA
ligase (New England Biolabs, Ipswich, MA, USA). Samples were then
Table 1
SNP call rates on the 250K array
DM call rate (%) Homozygotes (%) Hetero-zygotes (%) BRLMM call rate (%) Homo-zygotes (%) Hetero-zygotes (%)
Whole-genome ampliﬁcation
Genomic DNA WGA1 97.6 75.5 24.5 99.3 74.3 25.7
WGA2 95.8 75.6 24.4 99.0 73.0 27.0
WGA3 98.7 73.6 26.4 99.7 73.0 27.0
WGA4 97.7 74.6 25.5 99.5 73.1 26.9
Mean 97.5 74.8 25.2 99.4 73.4 26.6
SD 1.2 0.9 0.9 0.3 0.6 0.6
WGA DNA WGA1 94.3 75.7 24.3 97.4 73.4 26.6
WGA2 95.8 74.3 25.7 98.0 72.3 27.7
WGA3 95.0 74.9 25.1 97.1 71.9 28.1
WGA4 95.3 74.1 25.9 97.4 72.1 28.0
Mean 95.1 74.8 25.2 97.5 72.4 27.6
SD 0.6 0.7 0.7 0.4 0.7 0.7
Technical duplicates
Tech1A 97.1 74.1 26.0 99.3 72.8 27.2
Tech2A 96.5 73.7 26.3 98.8 72.5 27.5
Tech1B 94.7 75.3 24.7 98.3 72.7 27.4
Tech2B 97.8 73.9 26.1 99.3 73.2 26.9
Mean 96.5 74.2 25.8 98.9 72.8 27.2
SD 1.4 0.7 0.7 0.5 0.3 0.3
Table 3
Distribution of discordant SNPs
Whole-genome ampliﬁcation WGA1 WGA2 WGA3 WGA4
Overall concordance rate 98.79% 98.89% 98.37% 98.56%
Total discordant SNPs: 3069 2823 4149 3671
Het→Homoa 659 663 712 658
Homo→Homoa 16 23 73 63
453J. Xing et al. / Genomics 92 (2008) 452–456ampliﬁedbyPCRusing TITANIUM Taqpolymerase (Clontech,Mountain
View, CA, USA) on an MJ Tetrad PTC-225 machine (Bio-Rad, Hercules,
CA, USA). PCR products were pooled and puriﬁed using the Clontech
puriﬁcation kit and subjected to fragmentation using DNaseI (Affyme-
trix). The resulting DNA fragments were biotin-labeled with terminal
deoxynucleotidyl transferase (Affymetrix). Sampleswere then injected
into microarray cartridges and hybridized in a GeneChip® Hybridiza-
tion Oven 640 (Affymetrix), followed by washing and staining in a
GeneChip® Fluidics Station 450 (Affymetrix). Mapping array images
were obtained using the GeneChip Scanner 3000 7G (Affymetrix).
Genotype calling and data analysis
Genotypes for each experimentwere ﬁrst calledwith the Affymetrix
Dynamic Model algorithm (DM, [8]) to assess the quality of the
experiment, and all samples had call rates higher than the 93% threshold
recommended by Affymetrix. All samples were then called together
using the BRLMM algorithm [9] with default parameters. Analyses and
statistical tests were performed usingMATLAB (ver. r2008a). Genotypes
of all samples are available as supplemental ﬁle on our website (http://
jorde-lab.genetics.utah.edu) under Published Data.
Results
SNP call rate
DNA samples from six unrelated individuals were analyzed. Four of
the six samples (WGA1 toWGA4) were whole-genome ampliﬁed, andTable 2
No Call SNPs in the whole-genome ampliﬁed samples
WGA1 WGA2 WGA3 WGA4 Mean SD
Genomic DNA
AA (%) 37.7 37.1 37.1 37.2 37.3 0.3
AB (%) 25.7 27.0 27.0 26.9 26.6 0.6
BB (%) 36.6 35.9 35.9 36.0 36.1 0.3
Total SNPsa 260400 259728 261452 260889
WGA product
AA→No Call (%) 37.1 35.1 36.0 36.6 36.2 0.9
AB→No Call (%) 21.3 24.4 25.4 23.4 23.6 1.7
BB→No Call (%) 41.6 40.4 38.6 40.0 40.2 1.2
Total No Call SNPsb 6495 4994 7477 6546
a Total Number of called SNPs in each gDNA sample.
b Total Number of No Call SNPs in eachWGA sample that have genotype calls in their
corresponding gDNA samples.both template genomic DNA (gDNA) and whole-genome ampliﬁed
(WGA) products were hybridized on the Affymetrix Human Mapping
500K Arrays version NspI, which assays about 262,000 SNPs. The
remaining two samples (Tech1 and Tech2) were analyzed as technical
duplicates for which two identical array experiments were performed
on genomic DNA from each sample.
High-quality call rates were obtained for all 12 chips, and the initial
DMcall rates of all samples passed the 93% threshold recommended by
Affymetrix (Table 1). The sex of each sample was correctly inferred as
male. All 12 CEL ﬁles were then used for the BRLMM analysis. The
BRLMMcall rates of the four gDNA samples varied between 99.69% and
99.03%, with a mean of 99.37% and a standard deviation (SD) of 0.28%.
This result is comparable with the two technical duplicates, which had
an average call rate of 98.90% and a SD of 0.49%. The fourWGA samples
have slightly lower call rates compared to their corresponding gDNA
samples (Table 1), with an average call rate of 97.46% (1.91% lower than
gDNA samples) and a SD of 0.37%. There is no SNP that failed (i.e., over
the default No Call threshold) in all 12 samples.
To investigate the possible allele ampliﬁcation bias of the WGA
method, we selected SNPs that failed inWGA samples (“No Call” SNPs;Homo→Heta 2394 2137 3364 2950
Heterozygotes in gDNA 21.47% 23.49% 17.16% 17.92%
Heterozygotes in WGA 78.01% 75.70% 81.08% 80.36%
Technical duplicates Tech1A/1B Tech2A/2B
Overall concordance rate 99.55% 99.51%
Total discordant SNPs: 1146 1255
Het→Homoa 401 248
Homo→Homoa 4 6
Homo→Heta 741 1001
Heterozygotes in Highb 34.99% 19.76%
Heterozygotes in Lowb 64.66% 79.76%
a In whole-genome ampliﬁcation experiments, the genotype changes are calculated
based on the genomic DNA results. In technical duplicates, the number of genotype
changes is calculated based on the experiments with higher call rates. Homo:
Homozygotes, Het: Heterozygotes.
b Heterozygotes in High is the percentage of heterozygotes of the two experiments
with higher call rates in technical duplicates and Heterozygotes in Low is the percentage
of heterozygotes of the two experiments with lower call rates.
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proportion of calls in this set was compared with all SNPs on the array,
we found that the proportion of each genotype (AA, AB and BB) in No
Call SNPs is signiﬁcantly different from the proportion of each
genotype in all SNPs on the array (Table 2, chi-squared test, pb10−4
for each sample). There is a systematic decrease in AA, AB calls and an
increase in BB calls for the SNPs that failed in WGA experiments. On
average, SNPs that failed in WGA experiments showed a 3% decrease
in AA calls, 11.3% decrease in AB calls and 11.3% increase in BB calls
compared to all SNPs in the gDNA samples.
Concordance rate
To study the ﬁdelity of WGA products on the SNP array, we
calculated SNP concordance rates between gDNA and WGA samples
and between the two technical duplicates. In this analysis, only SNPs
that have genotypes in both experiments were considered. The two
technical duplicates have excellent concordance rates of 99.55% and
99.51%, respectively (Table 3). WGA samples have very high con-
cordance rates with gDNA samples as well: all four samples have
concordance rates greater than 98% (Table 3, mean=98.65%,
SD=0.24%). Among all SNPs that are discordant in any WGA/gDNA
comparisons (9925 total), the vast majority of the discordant callsFig. 1. C-score distribution of discordant SNPs C-scores are shown on the x-axis and the numb
sample pairs. C-scores of the gDNA samples are shown in blue and C-scores of theWGA samp
of the experiments with higher call rate in the duplicate are shown in blue and C-scores of(98.8%) are SNPs called as heterozygotes (AB) on one array but
homozygotes (AA or BB) on the other array. Only 1.2% of the discordant
calls are different homozygous calls (AA vs. BB) between the two
experiments.
To assess the genotyping quality of discordant calls, we examined
the conﬁdence score (C-score) of these SNPs. A C-score is the ratio of
the Mahalanobis distances between the observed allele signal value
and two nearest typical genotype values (see [9] for detail). C-score,
which varies between 0 and 1, is ameasure of the genotyping quality; a
smaller C-score indicates higher genotyping quality. A SNP with a C-
score N0.5 is assigned as a No Call by default.We found that the C-score
distribution of the discordant calls is signiﬁcantly different between
gDNA and WGA samples (Fig. 1A, two sample Kolmogorov–Smirnov
test, pb10−12). The higher C-scores of WGA samples show that there is
lower genotype-calling conﬁdence for discordant SNPs in the WGA
samples. Interestingly, a similar distribution difference is observed in
the discordant calls between technical duplicates: as might be
expected, the sample with a lower call rate in each pair has higher C-
scores (Fig. 1B, two sample Kolmogorov–Smirnov test, pb10−12).
Among discordant SNPs, WGA samples showed a signiﬁcantly higher
proportion of heterozygotes (N75% in each sample) compared to their
corresponding gDNA samples (chi-squared test, pb10−12; Table 3).
When the discordant calls between our two technical duplicates areer of SNPs is shown on the y-axis. (A) All discordant SNPs between the four gDNA/WGA
les are shown in red. (B) Discordant SNPs between the two technical duplicates. C-scores
the experiments with lower call rate in the duplicate are shown in red.
Fig. 2.Distribution of No Call SNPs and discordant SNPs on chromosome 1. The number of SNPs in 1Mb bins on chromosome 1 is shown. Blue, total number of SNPs on the 250K array;
green, number of SNPs that are No Call in at least three WGA samples; red, number of SNPs that are discordant in any of the four gDNA/WGA pairs.
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showed signiﬁcantly higher proportions of heterozygotes (chi-
squared test, pb10−12). Therefore, discordant calls for WGA samples
appear similar to discordant calls for low call rate genomic DNA
samples.
Genomic distribution of No Call and discordant SNPs
We next explore the possibility of systematic SNP calling failure in
WGA samples. There is little overlap between No Call SNPs among
WGA samples. Out of a total of 21,044 SNPs that failed in any of the four
WGA samples, only 144 (0.68%) failed in all four experiments. These
SNPs are dispersed across chromosomes, and no apparent clustering
can be observed. Similarly, only 1.23% of all discordant SNPs (169 out of
13,712) are discordant in all four WGA/gDNA comparisons. To further
investigate the distribution of No Call and discordant SNPs, we plotted
the number of total SNPs analyzed (∼262,200 total), the number of
SNPs that failed in at least three WGA experiments (4759 SNPs total)
and the number of SNPs that have discordant calls between anyWGA/
gDNA comparisons (9925 total) in 1Mb non-overlapping windows
across each chromosome (Supplemental Fig. 1). The SNP distribution
on chromosome 1 is shown in Fig. 2 as an example. The No Call SNPs
and discordant SNPs appear to be distributed across the genome andFig. 3. Performance of BRLMM at different C-score thresholds. Call Rates and concordance rat
Average concordance rates for the two technical duplicate pairs and the four gDNA/WGA pairs
duplicate samples, four gDNA samples and four WGA samples are shown in red, blue and gno apparent clustering of these SNPs is observed. As expected, the
number of SNPs failed in at least three WGA experiments showed a
small but signiﬁcant correlation with the overall SNP density in each
bin (Spearman's rank correlation rho=0.16, pb10−12). A very similar
trend is observed (rho=0.21, pb10−12) for discordant SNPs. Therefore,
the No Call and discordant SNPs are distributed across the whole
genome as a function of SNP coverage on the microarray.
Sensitivity vs. speciﬁcity of different BRLMM calling conﬁdence
thresholds
In the BRLMM calling process, a C-score is used to determine the
quality of genotype calls. To investigate the effect of different C-score
thresholds on the overall call rate and the concordance rate between
gDNA andWGA samples, we chose different C-score thresholds varying
from 0.5 to 0.05 and calculated the corresponding average call rates and
concordance rates for the fourWGA samples. As expected, using a more
stringent threshold increases the concordance rates between samples
but decreases the call rates (Fig. 3). We also analyzed the two technical
duplicates in the same procedure, and a very similar trend was
observed (Fig. 3, red curves). This result suggests that although WGA
samples have a lower overall call rate, their C-score distributions are
similar to those of gDNA samples.es for all six sample pairs are plotted against C-score thresholds varying from 0.5 to 0.05.
are shown in red and blue dashed lines respectively. Average call rates for four technical
reen solid lines respectively.
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In this study, we investigated the performance of whole-genome
ampliﬁed DNA on a commonly used Affymetrix 250K array. Because
the DNA samples used in this study are more than 10 years old and
have been refrigerated for most of this time, our ﬁndings should be
applicable to DNA samples stored by most standard methods in
common laboratories. The average WGA product call rate (97.5%) in
this study is generally higher than those of previous studies using
Affymetrix 10K SNP arrays [6,7] and Affymetrix 500K SNP arrays [10],
in which call rates of WGA products varied between ∼63% to ∼97%.
The higher call rate in this study is partly due to different quality of the
starting DNA (e.g. some ∼20 years old plasma and serum samples
were used in [10]), and partly due to the different genotype-calling
algorithms. The BRLMM calling algorithm used in this study has been
shown to provide signiﬁcant improvement over DM algorithm on the
500K array [9]. The average concordance rate (98.7%) in our samples is
comparable to previous studies, in which concordance rates range
from ∼81% to ∼99% [6,7,10]. It is noteworthy that, although our WGA
samples showed lower call rate compared to their corresponding
genomic DNA samples, call rates ofWGA samples are not always lower
than genomic DNAs. Among the 276 blood samples analyzed using the
same protocol in our laboratory that have passed the 93% DM call rate
threshold, 19 (7%) have BRLMM call rates below the 97.5% average call
rate of the four WGA samples in this study. In addition, a recent study
showed that imputation might be used to further improve the
performance of WGA products [11].
When the genomic distribution of No Call SNPs and discordant
SNPswere examined, we did not ﬁnd any apparent clustering patterns.
Only 144 SNPs failed in all four WGA experiments (0.68% of SNPs that
failed in any of theWGA experiments) and a total of 169 SNPs (1.23% of
all discordant SNPs) are discordant in all four comparisons. In general,
the genomic distribution of No Call and discordant SNPs correlates
with the SNP coverage of the genome on the array. The random
distribution and the lack of overlap of failed SNPs in different samples
suggest that most of the failures are due to variability among
experiments rather than systematic WGA ampliﬁcation problems.
Among SNPs that have discordant genotypes between gDNA andWGA
samples, we found an increase in heterozygotes in WGA samples. This
result is different from a previous study on the Affymetrix 10K array [6]
in which most of the discrepancies are “loss of heterozygosity” (AB to
AA/BB). This difference may due to the different microarray design
(10K vs. 250K) and the genotyping-calling algorithm used to generate
genotypes [6]. The BRLMM is known to improve the performance of
heterozygotes [9] and other studies using the Affymetrix 500K array
did not report a deﬁcit of heterozygotes [10,11].
It should be noted that the performance of the BRLMM calling
algorithm is thought to improve when more CEL ﬁles are analyzed
together [9]. In the description of BRLMM, at least six CEL ﬁles are
required for the run, and it is recommended to run more than 200
samples at a time to obtain optimal results. In our study, we analyzed
12 CEL ﬁles from 6 unrelated individuals. It is conceivable that
increasing the sample size could result in better concordance rates. To
test this hypothesis, we analyzed the current 12 samples with another
336 CEL ﬁles that were generated using the same protocol and
compared the resulting call rates and concordance rates. In WGAsamples, we observed a slight decrease in call rate (on average 2.31%)
but no appreciable increase in the average concordance rate (0.13%).
Therefore, despite the small sample size, our study closely represents
the general quality of genotype-calling with the BRLMM algorithm.
In summary, we found that WGA products are capable of
producing high-quality results on the Affymetrix 250K SNP array.
Using the BRLMM calling algorithm, WGA products have high call
rates and excellent concordance rates with their corresponding
genomic DNA samples. In addition, no apparent ampliﬁcation bias
across the genome can be detected for WGA products. These results
suggest that WGA is a promising solution for researchers and
clinicians who wants to perform large-scale array-based genotyping
but with limited amounts of DNA samples.
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